News

A new study to be presented at the SLEEP 2025 annual meeting found that sleep medicine professionals favor continuous ...
A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...
The FDA has been cut off from producing compounded weight-loss drugs such as Ozempic, Mounjaro or Wegovy, the most effective ...
Jim Gaffigan opens up about his 50lb weight loss using Mounjaro, sharing insights on feeling better, health benefits and ...
The medicines watchdog has issued an urgent warning about a deluge of social media advertisements for counterfeit weight-loss ...
FROM sulphur burps to diarrhoea and nausea, there are many widely known Ozempic side effects – but there’s also a whole host ...
Despite her active and healthy lifestyle, Sasha Barden felt stuck in her weight loss journey. She decided to try GLP-1 medications to support her weight loss goal. After six months on Wegovy ...
Big names in the fashion industry, such as the editorial director of British Vogue, Chioma Nnadi, has previously expressed ...
Eli Lilly and Company today announced that data from studies of orforglipron, insulin efsitora alfa, tirzepatide (Zepbound and Mounjaro), retatrutide, eloralintide and bimagrumab will be presented at ...
This study shows that midlife weight loss, without medical interventions ... (11-14 May), reveals distinct metabolic adjustments to tirzepatide and semaglutide treatment, with tirzepatide ...
Regeneron Pharmaceuticals has signed a new licensing agreement with Hansoh Pharmaceuticals Group to develop and sell its weight loss therapy outside of China.